LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,182,130 | -31.6% | 320,129 | -17.7% | 0.05% | -24.6% |
| Q2 2023 | $28,032,480 | +35.3% | 388,800 | +38.0% | 0.06% | +25.0% |
| Q1 2023 | $20,722,367 | +0.4% | 281,707 | -8.8% | 0.05% | -7.1% |
| Q4 2022 | $20,639,797 | -45.8% | 308,979 | -30.2% | 0.06% | -50.4% |
| Q3 2022 | $38,092,000 | -0.4% | 442,359 | +3.2% | 0.11% | -5.8% |
| Q2 2022 | $38,239,000 | +1.5% | 428,585 | +27.9% | 0.12% | +25.0% |
| Q1 2022 | $37,684,000 | -32.7% | 335,003 | -7.6% | 0.10% | -22.0% |
| Q4 2021 | $55,987,000 | +12.2% | 362,469 | +1.2% | 0.12% | +9.8% |
| Q3 2021 | $49,900,000 | -6.3% | 358,162 | -11.7% | 0.11% | -4.3% |
| Q2 2021 | $53,233,000 | +100.1% | 405,776 | +132.6% | 0.12% | +95.0% |
| Q1 2021 | $26,600,000 | -27.6% | 174,482 | -52.7% | 0.06% | -33.3% |
| Q4 2020 | $36,731,000 | +95.6% | 369,081 | +87.4% | 0.09% | +80.0% |
| Q3 2020 | $18,777,000 | – | 196,992 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |